|
Market Closed -
Nasdaq
20:00:00 27/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1.930 USD | +3.21% |
|
+3.21% | -47.27% |
Company Valuation: Fortress Biotech, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 249.1 | 71.14 | 54.57 | 55.9 | 113.6 | 64.37 | - |
| Change | - | -71.44% | -23.29% | 2.43% | 103.22% | -43.34% | - |
| Enterprise Value (EV) | 249.1 | 71.14 | 54.57 | 55.9 | 113.6 | 64.37 | 64.37 |
| Change | - | -71.44% | -23.29% | 2.43% | 103.22% | -43.34% | 0% |
| P/E | -3.16x | -0.68x | -0.36x | -0.75x | -52.3x | 0.76x | -1.93x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | -0x | 0x | 0x | 0.5x | -0x | 0x |
| Capitalization / Revenue | 3.62x | 0.94x | 0.65x | 0.97x | 1.8x | 0.82x | 0.57x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.82x | 0.57x |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -1.96x | -3.99x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -11.85 | -14.55 | -8.47 | -2.69 | -0.07 | 2.55 | -1 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 68.79 | 75.74 | 84.51 | 57.68 | 63.26 | 78.79 | 113.2 |
| EBITDA | -188.5 | - | - | -107.3 | -65.56 | - | - |
| EBIT 1 | -188.5 | -203.6 | -142.3 | -110.4 | -70.22 | -32.9 | -16.11 |
| Net income 1 | -64.7 | -86.58 | -68.67 | -46 | -1.882 | 88.25 | -37.81 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 37.500 | 9.825 | 3.010 | 2.025 | 3.660 | 1.930 | 1.930 |
| Nbr of stocks (in thousands) | 6,642 | 7,241 | 18,131 | 27,605 | 31,038 | 33,351 | - |
| Announcement Date | 28/03/22 | 30/03/23 | 28/03/24 | 31/03/25 | 31/03/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.73x | - | - | - | 62.37M | |
| 37.58x | 13.15x | 27.92x | 0.53% | 1,140B | |
| 38.98x | 6.55x | 18.43x | 2% | 641B | |
| 37.5x | 8.41x | 17.39x | 2.4% | 507B | |
| 21.33x | 5.19x | 12.91x | 2.53% | 383B | |
| 102.5x | 5.75x | 24.67x | 2.42% | 347B | |
| 21.61x | 5.64x | 13.85x | 2.84% | 293B | |
| 22.44x | 4.53x | 12.94x | 1.95% | 266B | |
| 28.21x | 7.23x | 12.94x | 2.27% | 240B | |
| -46.25x | 7.08x | 27.47x | 2.08% | 197B | |
| Average | 26.46x | 7.06x | 18.73x | 2.11% | 401.39B | |
| Weighted average by Cap. | 35.01x | 8.33x | 20.42x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- FBIO Stock
- Valuation Fortress Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
